96 related articles for article (PubMed ID: 31618644)
1. Type 2 Diabetes Variants in the SLC16A11 Coding Region Are Not Loss-of-Function Mutations.
Zhao Y; Feng Z; Ding Q
Cell Rep; 2019 Oct; 29(3):781-784. PubMed ID: 31618644
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes.
Zhao Y; Feng Z; Zhang Y; Sun Y; Chen Y; Liu X; Li S; Zhou T; Chen L; Wei Y; Ma D; Lui KO; Ying H; Chen Y; Ding Q
Cell Rep; 2019 Jan; 26(4):884-892.e4. PubMed ID: 30673611
[TBL] [Abstract][Full Text] [Related]
3. Gain-of-Function Claims for Type-2-Diabetes-Associated Coding Variants in SLC16A11 Are Not Supported by the Experimental Data.
Hoch E; Florez JC; Lander ES; Jacobs SBR
Cell Rep; 2019 Oct; 29(3):778-780. PubMed ID: 31618643
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.
Rusu V; Hoch E; Mercader JM; Tenen DE; Gymrek M; Hartigan CR; DeRan M; von Grotthuss M; Fontanillas P; Spooner A; Guzman G; Deik AA; Pierce KA; Dennis C; Clish CB; Carr SA; Wagner BK; Schenone M; Ng MCY; Chen BH; ; ; Centeno-Cruz F; Zerrweck C; Orozco L; Altshuler DM; Schreiber SL; Florez JC; Jacobs SBR; Lander ES
Cell; 2017 Jun; 170(1):199-212.e20. PubMed ID: 28666119
[TBL] [Abstract][Full Text] [Related]
5. The SLC16A11 risk haplotype is associated with decreased insulin action, higher transaminases and large-size adipocytes.
Almeda-Valdes P; Gómez Velasco DV; Arellano Campos O; Bello-Chavolla OY; Del Rocío Sevilla-González M; Viveros Ruiz T; Martagón Rosado AJ; Bautista CJ; Muñoz Hernandez L; Cruz-Bautista I; Moreno-Macias H; Huerta-Chagoya A; Rodríguez-Álvarez KG; Walford GA; Jacobs SBR; Guillen Pineda LE; Ordoñez-Sánchez ML; Roldan-Valadez E; Azpiroz J; Furuzawa-Carballeda J; Clark P; Herrera-Hernández MF; Zambrano E; Florez JC; Tusié Luna MT; Aguilar-Salinas CA
Eur J Endocrinol; 2019 Feb; 180(2):99-107. PubMed ID: 30475225
[TBL] [Abstract][Full Text] [Related]
6. The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.
Kimura Y; Higuchi I; Kobayashi M; Furugen A; Narumi K; Suzuki Y; Miyoshi H; Nakamura A; Atsumi T; Iseki K
Drug Metab Pharmacokinet; 2021 Apr; 37():100376. PubMed ID: 33561739
[TBL] [Abstract][Full Text] [Related]
7. Epistasis Between HLA-DRB1*16:02:01 and SLC16A11 T-C-G-T-T Reduces Odds for Type 2 Diabetes in Southwest American Indians.
Williams RC; Hanson RL; Peters B; Kearns K; Knowler WC; Bogardus C; Baier LJ
Diabetes; 2024 Jun; 73(6):1002-1011. PubMed ID: 38530923
[TBL] [Abstract][Full Text] [Related]
8. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico.
; Williams AL; Jacobs SB; Moreno-Macías H; Huerta-Chagoya A; Churchhouse C; Márquez-Luna C; García-Ortíz H; Gómez-Vázquez MJ; Burtt NP; Aguilar-Salinas CA; González-Villalpando C; Florez JC; Orozco L; Haiman CA; Tusié-Luna T; Altshuler D
Nature; 2014 Feb; 506(7486):97-101. PubMed ID: 24390345
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the
Mardones L; Petermann-Rocha F; Martinez-Sanguinetti MA; Leiva AM; Troncoso-Pantoja C; Martorell M; Lasserre N; Ulloa N; Perez-Bravo F; Celis-Morales C; Villagran M;
Arch Endocrinol Metab; 2021 Nov; 65(3):305-314. PubMed ID: 33909378
[TBL] [Abstract][Full Text] [Related]
10. The role of SLC16A11 variations in diabetes mellitus.
Aguilar-Salinas CA; Tusie Luna MT
Curr Opin Nephrol Hypertens; 2023 Sep; 32(5):445-450. PubMed ID: 37530085
[TBL] [Abstract][Full Text] [Related]
11. Associations of common variants in the SLC16A11, TCF7L2, and ABCA1 genes with pediatric-onset type 2 diabetes and related glycemic traits in families: A case-control and case-parent trio study.
Miranda-Lora AL; Cruz M; Molina-Díaz M; Gutiérrez J; Flores-Huerta S; Klünder-Klünder M
Pediatr Diabetes; 2017 Dec; 18(8):824-831. PubMed ID: 28101933
[TBL] [Abstract][Full Text] [Related]
12. Diabetes susceptibility in Mayas: Evidence for the involvement of polymorphisms in HHEX, HNF4α, KCNJ11, PPARγ, CDKN2A/2B, SLC30A8, CDC123/CAMK1D, TCF7L2, ABCA1 and SLC16A11 genes.
Lara-Riegos JC; Ortiz-López MG; Peña-Espinoza BI; Montúfar-Robles I; Peña-Rico MA; Sánchez-Pozos K; Granados-Silvestre MA; Menjivar M
Gene; 2015 Jul; 565(1):68-75. PubMed ID: 25839936
[TBL] [Abstract][Full Text] [Related]
13. Analysis of SLC16A11 Variants in 12,811 American Indians: Genotype-Obesity Interaction for Type 2 Diabetes and an Association With RNASEK Expression.
Traurig M; Hanson RL; Marinelarena A; Kobes S; Piaggi P; Cole S; Curran JE; Blangero J; Göring H; Kumar S; Nelson RG; Howard BV; Knowler WC; Baier LJ; Bogardus C
Diabetes; 2016 Feb; 65(2):510-9. PubMed ID: 26487785
[TBL] [Abstract][Full Text] [Related]
14. Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women.
Huerta-Chagoya A; Vázquez-Cárdenas P; Moreno-Macías H; Tapia-Maruri L; Rodríguez-Guillén R; López-Vite E; García-Escalante G; Escobedo-Aguirre F; Parra-Covarrubias A; Cordero-Brieño R; Manzo-Carrillo L; Zacarías-Castillo R; Vargas-García C; Aguilar-Salinas C; Tusié-Luna T
PLoS One; 2015; 10(5):e0126408. PubMed ID: 25973943
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population.
Kimura Y; Kobayashi M; Asari M; Higuchi I; Narumi K; Furugen A; Iseki K
Drug Metab Pharmacokinet; 2018 Oct; 33(5):215-218. PubMed ID: 30177396
[TBL] [Abstract][Full Text] [Related]
16. Human genetics uncovers
Nag A; Dhindsa RS; Mitchell J; Vasavda C; Harper AR; Vitsios D; Ahnmark A; Bilican B; Madeyski-Bengtson K; Zarrouki B; Zoghbi AW; Wang Q; Smith KR; Alegre-Díaz J; Kuri-Morales P; Berumen J; Tapia-Conyer R; Emberson J; Torres JM; Collins R; Smith DM; Challis B; Paul DS; Bohlooly-Y M; Snowden M; Baker D; Fritsche-Danielson R; Pangalos MN; Petrovski S
Sci Adv; 2022 Nov; 8(46):eadd5430. PubMed ID: 36383675
[TBL] [Abstract][Full Text] [Related]
17. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
18. Effects of genetic variations in the genes encoding NOD1 and NOD2 on type 2 diabetes mellitus and insulin resistance.
Ozbayer C; Kurt H; Kebapci MN; Gunes HV; Colak E; Degirmenci I
J Clin Pharm Ther; 2017 Feb; 42(1):98-102. PubMed ID: 27885704
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.
Mathison A; Escande C; Calvo E; Seo S; White T; Salmonson A; Faubion WA; Buttar N; Iovanna J; Lomberk G; Chini EN; Urrutia R
Endocrinology; 2015 Oct; 156(10):3581-95. PubMed ID: 26248217
[TBL] [Abstract][Full Text] [Related]
20. Variants of NLRP3 gene are associated with insulin resistance in Chinese Han population with type-2 diabetes.
Zheng Y; Zhang D; Zhang L; Fu M; Zeng Y; Russell R
Gene; 2013 Nov; 530(1):151-4. PubMed ID: 23973727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
